Metastatic phenotype and immunosuppressive tumour microenvironment in pancreatic ductal adenocarcinoma: Key role of the urokinase plasminogen activator (PLAU)
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metastatic phenotype and immunosuppressive tumour microenvironment in pancreatic ductal adenocarcinoma: Key role of the urokinase plasminogen activator (PLAU)
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-12-14
DOI
10.3389/fimmu.2022.1060957
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Therapeutic Strategies Targeting Urokinase and Its Receptor in Cancer
- (2022) Maria Teresa Masucci et al. Cancers
- The Urokinase Plasminogen Activation System in Pancreatic Cancer: Prospective Diagnostic and Therapeutic Targets
- (2022) Ashna A. Kumar et al. Biomolecules
- Urokinase plasminogen activator induces epithelial-mesenchymal and metastasis of pancreatic cancer through plasmin/MMP14/TGF-β axis, which is inhibited by 4-acetyl-antroquinonol B treatment
- (2022) Chung-Ze Wu et al. PHYTOMEDICINE
- Dynamic profiling of immune microenvironment during pancreatic cancer development suggests early intervention and combination strategy of immunotherapy
- (2022) Jiaqi Yang et al. EBioMedicine
- Molecular Subtyping and Precision Medicine for Pancreatic Cancer
- (2021) Fieke Froeling et al. Journal of Clinical Medicine
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Integrated cross-study datasets of genetic dependencies in cancer
- (2021) Clare Pacini et al. Nature Communications
- PLAU directs conversion of fibroblasts to inflammatory cancer-associated fibroblasts, promoting esophageal squamous cell carcinoma progression via uPAR/Akt/NF-κB/IL8 pathway
- (2021) Lingling Fang et al. Cell Death Discovery
- Comparison between FOLFIRINOX and gemcitabine plus nab-paclitaxel including sequential treatment for metastatic pancreatic cancer: a propensity score matching approach
- (2021) Jung Won Chun et al. BMC CANCER
- PLAU Promotes Cell Proliferation and Epithelial-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma
- (2021) Guangjin Chen et al. Frontiers in Genetics
- WNT Ligand Dependencies in Pancreatic Cancer
- (2021) Kristina Y. Aguilera et al. Frontiers in Cell and Developmental Biology
- Experimental and Clinical Evidence Supports the Use of Urokinase Plasminogen Activation System Components as Clinically Relevant Biomarkers in Gastroesophageal Adenocarcinoma
- (2021) Gary Tincknell et al. Cancers
- Novel Insight Into Glycosaminoglycan Biosynthesis Based on Gene Expression Profiles
- (2021) Yi-Fan Huang et al. Frontiers in Cell and Developmental Biology
- Advances and Utility of the Human Plasma Proteome
- (2021) Eric W. Deutsch et al. JOURNAL OF PROTEOME RESEARCH
- uPAR Controls Vasculogenic Mimicry Ability Expressed by Drug-Resistant Melanoma Cells
- (2021) Elena Andreucci et al. ONCOLOGY RESEARCH
- PPP1R14B Is a Prognostic and Immunological Biomarker in Pan-Cancer
- (2021) Mingxia Deng et al. Frontiers in Genetics
- Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution
- (2020) Michelle Chan-Seng-Yue et al. NATURE GENETICS
- Pancreatic stellate cells: Aiding and abetting pancreatic cancer progression
- (2020) Srinivasa P. Pothula et al. PANCREATOLOGY
- Targeting the HGF/c-MET pathway in advanced pancreatic cancer: a key element of treatment that limits primary tumour growth and eliminates metastasis
- (2020) Zhihong Xu et al. BRITISH JOURNAL OF CANCER
- GATA6 Expression Distinguishes Classical and Basal-like Subtypes in Advanced Pancreatic Cancer
- (2020) Grainne M. O'Kane et al. CLINICAL CANCER RESEARCH
- HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer
- (2020) Holly Brunton et al. Cell Reports
- Regulation of glycolysis by the hypoxia‐inducible factor (HIF): implications for cellular physiology
- (2020) S. J. Kierans et al. JOURNAL OF PHYSIOLOGY-LONDON
- The dual role of the glycosaminoglycan chondroitin-6-sulfate in the development, progression and metastasis of cancer
- (2019) Adam Pudełko et al. FEBS Journal
- Experimental microdissection enables functional harmonisation of pancreatic cancer subtypes
- (2019) Hans Carlo Maurer et al. GUT
- EGFR/uPAR interaction as druggable target to overcome vemurafenib acquired resistance in melanoma cells
- (2019) Anna Laurenzana et al. EBioMedicine
- The prognostic relevance of urokinase-type plasminogen activator (uPA) in the blood of patients with metastatic breast cancer
- (2019) Malgorzata Banys-Paluchowski et al. Scientific Reports
- Integration of Genomic and Transcriptional Features in Pancreatic Cancer Reveals Increased Cell Cycle Progression in Metastases
- (2019) Ashton A. Connor et al. CANCER CELL
- Next-generation characterization of the Cancer Cell Line Encyclopedia
- (2019) Mahmoud Ghandi et al. NATURE
- Identification of Transcriptional Signatures of Colon Tumor Stroma by a Meta-Analysis
- (2019) Md. Nazim Uddin et al. Journal of Oncology
- Morphological classification of pancreatic ductal adenocarcinoma that predicts molecular subtypes and correlates with clinical outcome
- (2019) Sangeetha N Kalimuthu et al. GUT
- Durvalumab With or Without Tremelimumab for Patients With Metastatic Pancreatic Ductal Adenocarcinoma
- (2019) Eileen M. O’Reilly et al. JAMA Oncology
- The enhancement of glycolysis regulates pancreatic cancer metastasis
- (2019) Jinshou Yang et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Proteomic analyses of ECM during pancreatic ductal adenocarcinoma progression reveal different contributions by tumor and stromal cells
- (2019) Chenxi Tian et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Purity Independent Subtyping of Tumors (PurIST), A Clinically Robust, Single-sample Classifier for Tumor Subtyping in Pancreatic Cancer
- (2019) Naim U. Rashid et al. CLINICAL CANCER RESEARCH
- Identification of potential hub genes associated with the pathogenesis and prognosis of pancreatic duct adenocarcinoma using bioinformatics meta‑analysis of multi‑platform datasets
- (2019) Yufan Ma et al. Oncology Letters
- Myeloid-Derived Suppressor Cells and Pancreatic Cancer: Implications in Novel Therapeutic Approaches
- (2019) Anita Thyagarajan et al. Cancers
- Cancer-Cell-Intrinsic Mechanisms Shaping the Tumor Immune Landscape
- (2018) Max D. Wellenstein et al. IMMUNITY
- Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor–stroma crosstalk
- (2018) Carlos A. Orozco et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Involvement of anti-tumor miR-124-3p and its targets in the pathogenesis of pancreatic ductal adenocarcinoma: direct regulation of ITGA3 and ITGB1 by miR-124-3p
- (2018) Tetsuya Idichi et al. Oncotarget
- Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and Its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic Applications
- (2018) Niaz Mahmood et al. Frontiers in Oncology
- 6-Substituted Hexamethylene Amiloride (HMA) Derivatives as Potent and Selective Inhibitors of the Human Urokinase Plasminogen Activator for Use in Cancer
- (2018) Benjamin J. Buckley et al. JOURNAL OF MEDICINAL CHEMISTRY
- Stratification of Pancreatic Ductal Adenocarcinomas Based on Tumor and Microenvironment Features
- (2018) Francesco Puleo et al. GASTROENTEROLOGY
- Network-based integration of mRNA and miRNA profiles reveals new target genes involved in pancreatic cancer
- (2018) Jie Lin et al. MOLECULAR CARCINOGENESIS
- FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
- (2018) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets
- (2018) Damian Szklarczyk et al. NUCLEIC ACIDS RESEARCH
- TP63-Mediated Enhancer Reprogramming Drives the Squamous Subtype of Pancreatic Ductal Adenocarcinoma
- (2018) Tim D.D. Somerville et al. Cell Reports
- uPA/uPAR system activation drives a glycolytic phenotype in melanoma cells
- (2017) Anna Laurenzana et al. INTERNATIONAL JOURNAL OF CANCER
- Validation and comparison of the molecular classifications of pancreatic carcinomas
- (2017) David J. Birnbaum et al. Molecular Cancer
- Targeting the HGF/c-MET pathway: stromal remodelling in pancreatic cancer
- (2017) Srinivasa P. Pothula et al. Oncotarget
- Prognostic relevance of molecular subtypes and master regulators in pancreatic ductal adenocarcinoma
- (2016) Rekin’s Janky et al. BMC CANCER
- Hepatocyte growth factor inhibition: a novel therapeutic approach in pancreatic cancer
- (2016) Srinivasa P Pothula et al. BRITISH JOURNAL OF CANCER
- Hypoxic stellate cells of pancreatic cancer stroma regulate extracellular matrix fiber organization and cancer cell motility
- (2016) Masafumi Sada et al. CANCER LETTERS
- Molecular subtypes of pancreatic cancer based on miRNA expression profiles have independent prognostic value
- (2016) Junghyun Namkung et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Genomic analyses identify molecular subtypes of pancreatic cancer
- (2016) Peter Bailey et al. NATURE
- Wnt signaling in cancer
- (2016) T Zhan et al. ONCOGENE
- Globally increased ultraconserved noncoding RNA expression in pancreatic adenocarcinoma
- (2016) Jinmai Jiang et al. Oncotarget
- Pancreatic stellate cell secreted IL-6 stimulates STAT3 dependent invasiveness of pancreatic intraepithelial neoplasia and cancer cells
- (2016) Nagaraj S. Nagathihalli et al. Oncotarget
- Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
- (2015) Chih-Hao Chang et al. CELL
- Activation of pancreatic stellate cells involves an EMT-like process
- (2015) LEI TIAN et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma
- (2015) Richard A Moffitt et al. NATURE GENETICS
- Resveratrol inhibits hypoxia-driven ROS-induced invasive and migratory ability of pancreatic cancer cells via suppression of the Hedgehog signaling pathway
- (2015) WEI LI et al. ONCOLOGY REPORTS
- Pancreatic cancer: The microenvironment needs attention too!
- (2015) M.V. Apte et al. PANCREATOLOGY
- Tissue-based map of the human proteome
- (2015) M. Uhlen et al. SCIENCE
- Urokinase receptor and resistance to targeted anticancer agents
- (2015) Steven L. Gonias et al. Frontiers in Pharmacology
- Pancreatic Adenocarcinoma
- (2015) David P. Ryan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Activation of Pro-uPA Is Critical for Initial Escape from the Primary Tumor and Hematogenous Dissemination of Human Carcinoma Cells
- (2015) Erin M. Bekes et al. NEOPLASIA
- Identifying molecular subtypes related to clinicopathologic factors in pancreatic cancer
- (2014) Shinuk Kim et al. Biomedical Engineering Online
- cytoHubba: identifying hub objects and sub-networks from complex interactome
- (2014) Chia-Hao Chin et al. BMC Systems Biology
- Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
- (2014) L. Rahib et al. CANCER RESEARCH
- The complex landscape of pancreatic cancer metabolism
- (2014) C. M. Sousa et al. CARCINOGENESIS
- The extracellular matrix modulates the hallmarks of cancer
- (2014) M. W. Pickup et al. EMBO REPORTS
- Generation and Characterisation of Novel Pancreatic Adenocarcinoma Xenograft Models and Corresponding Primary Cell Lines
- (2014) Anna B. Wennerström et al. PLoS One
- Stars and stripes in pancreatic cancer: role of stellate cells and stroma in cancer progression
- (2014) Jeremy S. Wilson et al. Frontiers in Physiology
- Phase II randomised proof-of-concept study of the urokinase inhibitor upamostat (WX-671) in combination with gemcitabine compared with gemcitabine alone in patients with non-resectable, locally advanced pancreatic cancer
- (2013) V Heinemann et al. BRITISH JOURNAL OF CANCER
- Canonical Wnt Signaling Is Required for Pancreatic Carcinogenesis
- (2013) Y. Zhang et al. CANCER RESEARCH
- Evaluation of Ipilimumab in Combination With Allogeneic Pancreatic Tumor Cells Transfected With a GM-CSF Gene in Previously Treated Pancreatic Cancer
- (2013) Dung T. Le et al. JOURNAL OF IMMUNOTHERAPY
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
- (2013) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- Inferring tumour purity and stromal and immune cell admixture from expression data
- (2013) Kosuke Yoshihara et al. Nature Communications
- Pancreatic cancer-associated stellate cells
- (2013) Thomas A Mace et al. OncoImmunology
- Targeting Urokinase and the Transferrin Receptor with Novel, Anti-Mitotic N-Alkylisatin Cytotoxin Conjugates Causes Selective Cancer Cell Death and Reduces Tumor Growth
- (2012) K. L. Vine et al. CURRENT CANCER DRUG TARGETS
- Persistent activation of pancreatic stellate cells creates a microenvironment favorable for the malignant behavior of pancreatic ductal adenocarcinoma
- (2012) Dong Tang et al. INTERNATIONAL JOURNAL OF CANCER
- Molecular signatures database (MSigDB) 3.0
- (2011) A. Liberzon et al. BIOINFORMATICS
- The Urokinase-type Plasminogen Activator and the Generation of Inhibitors of Urokinase Activity and Signaling
- (2011) Maria Vincenza Carriero et al. CURRENT PHARMACEUTICAL DESIGN
- Extracellular matrix players in metastatic niches
- (2011) Thordur Oskarsson et al. EMBO JOURNAL
- Cancer therapy trials employing level-of-evidence-1 disease forecast cancer biomarkers uPA and its inhibitor PAI-1
- (2011) Manfred Schmitt et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- High expression of Galectin-1 in pancreatic stellate cells plays a role in the development and maintenance of an immunosuppressive microenvironment in pancreatic cancer
- (2011) Dong Tang et al. INTERNATIONAL JOURNAL OF CANCER
- Interactions between cancer stem cells and their niche govern metastatic colonization
- (2011) Ilaria Malanchi et al. NATURE
- Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy
- (2011) Eric A Collisson et al. NATURE MEDICINE
- Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs
- (2011) Thordur Oskarsson et al. NATURE MEDICINE
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Role of Pancreatic Stellate Cells in Pancreatic Cancer Metastasis
- (2010) Zhihong Xu et al. AMERICAN JOURNAL OF PATHOLOGY
- Wnt/β-Catenin Pathway Activation Is Enriched in Basal-Like Breast Cancers and Predicts Poor Outcome
- (2010) Andrey I. Khramtsov et al. AMERICAN JOURNAL OF PATHOLOGY
- CD10+ Pancreatic Stellate Cells Enhance the Progression of Pancreatic Cancer
- (2010) Naoki Ikenaga et al. GASTROENTEROLOGY
- Phase 2 Trial of Single Agent Ipilimumab (Anti-CTLA-4) for Locally Advanced or Metastatic Pancreatic Adenocarcinoma
- (2010) Richard E. Royal et al. JOURNAL OF IMMUNOTHERAPY
- Physico-mechanical aspects of extracellular matrix influences on tumorigenic behaviors
- (2010) Edna Cukierman et al. SEMINARS IN CANCER BIOLOGY
- FKBP51 Affects Cancer Cell Response to Chemotherapy by Negatively Regulating Akt
- (2009) Huadong Pei et al. CANCER CELL
- The multifaceted role of periostin in tumorigenesis
- (2009) Kai Ruan et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Regulation of cell signalling by uPAR
- (2009) Harvey W. Smith et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The Oral Serine Protease Inhibitor WX-671 – First Experience in Patients with Advanced Head and Neck Carcinoma
- (2008) Jens E. Meyer et al. Breast Care
- Experience in Phase I Trials and an Upcoming Phase II Study with uPA Inhibitors in Metastatic Breast Cancer
- (2008) Lori J. Goldstein Breast Care
- Pancreatic Stellate Cells and Pancreatic Cancer Cells: An Unholy Alliance
- (2008) A. Vonlaufen et al. CANCER RESEARCH
- Pancreatic Stellate Cells: Partners in Crime with Pancreatic Cancer Cells
- (2008) A. Vonlaufen et al. CANCER RESEARCH
- Periostin, secreted from stromal cells, has biphasic effect on cell migration and correlates with the epithelial to mesenchymal transition of human pancreatic cancer cells
- (2008) Atsushi Kanno et al. INTERNATIONAL JOURNAL OF CANCER
- Role of Ras Signaling in the Induction of Snail by Transforming Growth Factor-β
- (2008) Kana Horiguchi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- TGF-β signaling preserves RECK expression in activated pancreatic stellate cells
- (2008) Hongsik Lee et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Pancreatic Cancer Stem Cells
- (2008) Cheong J. Lee et al. JOURNAL OF CLINICAL ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started